| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.3 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |